CSTL Stock: Price, Earnings History and SEC Filings
Castle Biosciences, Inc. (CSTL) last traded at $37.16, down 3.51% on the latest session and up 4.6% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.07 against an analyst estimate of $-0.44, a beat of 84.1%.
$37.16 -3.51%
1 month+4.59%
52-week high$44.28
52-week low$17.72
Volume334,260
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
CSTL earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Jul 30, 2026 | $-0.07 | $-0.44 | +84.09% |
| Mar 2026 | May 6, 2026 | $-0.49 | $-0.56 | +12.50% |
| Dec 2025 | Feb 26, 2026 | $-0.08 | $-0.23 | +65.22% |
| Sep 2025 | Nov 3, 2025 | $-0.02 | $-0.34 | +94.12% |
CSTL beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for CSTL
SEC filing data is not available right now. You can search for CSTL on SEC EDGAR.
CSTL news
- Castle Biosciences to Participate in Upcoming Investor ConferencesOct 28, 2026 · finance.yahoo.com
About Castle Biosciences, Inc.
Castle Biosciences, Inc. (CSTL) is a US-listed public company on Nasdaq.